Form 4: Hims & Hers Health Executive Exercises Options and Sells Shares
SEC Form 4 Filing
A Hims & Hers Health executive exercised stock options and sold shares under a pre-arranged trading plan.
Summary
- Michael Chi, Chief Commercial Officer at Hims & Hers Health, exercised stock options to acquire 7,259 shares of Class A Common Stock at a price of $6.82 per share.
- Simultaneously, Mr. Chi sold 7,259 shares of Class A Common Stock at a price of $32.25 per share.
- These transactions were executed on December 10, 2024, and were part of a pre-arranged Rule 10b5-1 trading plan adopted on March 1, 2024.
- The stock options are subject to a four-year vesting schedule, with 1/48th of the options vesting monthly starting September 10, 2022.
Sentiment
Score: 5
Explanation: The document describes a routine transaction by an executive, with no indication of positive or negative sentiment. It is a standard practice for executives to exercise options and sell shares.
Industry Context
This is a routine transaction for executives who receive stock options as part of their compensation. The use of a Rule 10b5-1 trading plan is a common practice to avoid accusations of insider trading.
Comparison to Industry Standards
- The use of a Rule 10b5-1 trading plan is standard practice for executives at publicly traded companies like Hims & Hers Health to manage their stock transactions.
- The vesting schedule of the stock options is typical for executive compensation packages, often spanning several years to align executive interests with long-term company performance.
- The difference between the exercise price and the sale price is a common outcome for stock options, reflecting the increase in the company's stock value since the options were granted.
Stakeholder Impact
- The transactions have a minor impact on shareholders, as they represent a small portion of the total outstanding shares.
- The sale of shares by an executive could be perceived as a negative signal by some investors, but the pre-arranged nature of the transaction mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 2022-09-10 | Start date for monthly vesting of stock options. |
| 2024-03-01 | Date the Rule 10b5-1 trading plan was adopted. |
| 2024-12-10 | Date of stock option exercise and share sale. |
| 2024-12-11 | Date of filing the Form 4. |
| 2032-08-10 | Expiration date of the stock options. |
Keywords
Hims & Hers Health, stock options, insider trading, Rule 10b5-1, executive compensation, share sale, vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.